BASI Financial Facts

Diluted net income (loss) per share: 0.16
Total operating expenses: 956K
See Full Income Statement

Other assets: 34K
Goodwill: 1.01M
See Full Balance Sheet

Bioanalytical Systems (BASI) Earnings

  |   Expand Research on BASI
Next EPS Date 12/22/15 *Est. EPS Growth Rate +700.0% *Last Qtr.
Average EPS % Beat Rate -125.0% Revenue Growth Rate +2.0% *Last Qtr.
Average % Move 1-Wk after EPS +8.9% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/13/15 Q315 $0.16N/A N/A $6.15M$6.03M N/A Details
5/14/15 Q215 -$0.01N/A N/A $5.73M$5.92M N/A Details
2/12/15 Q115 $0.01N/A N/A $5.85M$6.22M N/A Details
12/22/14 Q414 -$0.02N/A N/A $6.42M$5.51M N/A Details
8/14/14 Q314 $0.02N/A N/A $6.03M$5.6M N/A Details
5/15/14 Q214 -$0.03N/A N/A $5.91M$5.16M N/A Details
2/13/14 Q114 $0.04N/A N/A $6.22M$5.8M N/A Details
12/24/13 Q413 $0.03N/A N/A $5.51M$6.54M N/A Details